Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ summarises the EULabCap indicator results in the chapter on public health laboratory capacity to control infectious disease threats.
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
High rate of acquisition of faecal carriage of multidrug-resistant Enterobacteriaceae after international travel
The study by Ruppé et al. is the largest study to date that confirms the high frequency of faecal carriage of multidrug-resistant Enterobacteriaceae in European travellers returning from Asia, Africa or Latin America each year.
EU and US team up in the fight against antimicrobial resistance
The first progress report of the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) was published today. It reviews the implementation of the set of recommendations defined by the TATFAR in 2012, for a better cooperation in the global fight to keep antimicrobials effective.
WHO’s first global report on surveillance of antimicrobial resistance with data from 114 countries
‘Antimicrobial resistance: global report on surveillance’ published by WHO today gives the most comprehensive picture of antibiotic resistance to date, with data from 114 countries. The report examines the current status of surveillance and information on AMR, with a focus on antibacterial resistance at country level, worldwide.
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.
A review of the effect of immunization programs on antimicrobial utilizationArchived
Antimicrobial stewardship policies are increasingly being implemented as a measure to prevent and control antimicrobial resistance.
US CDC guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – 2012 CRE toolkitArchived
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and AustraliaArchived
While the discovery of antibiotics revolutionised the way we treat patients with bacterial infections, bacteria have become increasingly resistant to antibiotics, mostly due to the misuse of these medicines.